Steven Gannon
Director · 3 filings · Latest: Aug 11, 2026
Xenon Pharmaceuticals Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XENE | Steven Gannon | Director | Aug 11, 2026 | Sale | $64.06 | 10,000 | $640.6K | 1,870 | |
XENE | STEVEN GANNON | — | Aug 11, 2026 | Proposed Sale | $64.06 | 10,000 | $640.6K | — | |
XENE | Steven Gannon | Director | Jun 1, 2026 | Option Exercise | — | 2,645 | — | 13,286 | |
XENE | Steven Gannon | Director | May 12, 2026 | Option Exercise | $7.38 | 3,500 | $25.8K | 10,641 |